Follow
Melissa F. Adasme
Title
Cited by
Cited by
Year
PLIP: fully automated protein–ligand interaction profiler
S Salentin, S Schreiber, VJ Haupt, MF Adasme, M Schroeder
Nucleic acids research 43 (W1), W443-W447, 2015
16522015
PLIP 2021: Expanding the scope of the protein–ligand interaction profiler to DNA and RNA
MF Adasme, KL Linnemann, SN Bolz, F Kaiser, S Salentin, VJ Haupt, ...
Nucleic acids research 49 (W1), W530-W534, 2021
7482021
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
D Parisi, MF Adasme, A Sveshnikova, SN Bolz, Y Moreau, M Schroeder
Computational and Structural Biotechnology Journal 18, 1043-1055, 2020
592020
From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns
S Salentin, MF Adasme, JC Heinrich, VJ Haupt, S Daminelli, Y Zhang, ...
Scientific reports 7 (1), 11401, 2017
472017
Structure-based drug repositioning: potential and limits
MF Adasme, D Parisi, A Sveshnikova, M Schroeder
Seminars in cancer biology 68, 192-198, 2021
292021
Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
MF Adasme, D Parisi, K Van Belle, S Salentin, VJ Haupt, GS Jennings, ...
PLoS One 15 (5), e0233089, 2020
252020
Toward an understanding of pan-assay interference compounds and promiscuity: a structural perspective on binding modes
SN Bolz, MF Adasme, M Schroeder
Journal of Chemical Information and Modeling 61 (5), 2248-2262, 2021
242021
Repositioned drugs for chagas disease unveiled via structure-based drug repositioning
MF Adasme, SN Bolz, L Adelmann, S Salentin, VJ Haupt, ...
International Journal of Molecular Sciences 21 (22), 8809, 2020
242020
The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods
B Zdrazil, E Felix, F Hunter, EJ Manners, J Blackshaw, S Corbett, ...
Nucleic acids research 52 (D1), D1180-D1192, 2024
162024
Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery
SW Poser, O Otto, C Arps-Forker, Y Ge, M Herbig, C Andree, ...
The FASEB Journal, 2019
82019
Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening
MF Adasme, SN Bolz, A Al-Fatlawi, M Schroeder
Journal of Cheminformatics 14 (1), 17, 2022
32022
Structure based drug repositioning by exploiting structural properties of drug's binding mode
MF Adasme
2021
The system can't perform the operation now. Try again later.
Articles 1–12